
HIV/AIDS & STIs
HIV/AIDS and sexually transmitted infections (STIs) remain critical global health concerns, affecting millions annually and contributing to significant morbidity and mortality. Addressing these challenges requires comprehensive prevention, education, and treatment strategies, alongside efforts to reduce stigma and expand access to testing and antiretroviral therapies, to achieve lasting public health impact.
94
Member Organizations
Stronger
Together for Impact
18
Countries Represented
Evidence
Policy in Action
Objectives
Advance Service Integration
Promote coordinated prevention, diagnosis, treatment, and referral services across HIV, STIs, and related health priorities.
Strengthen Sustainable Financing
Advocate for flexible, equitable funding that enables integrated services and long-term community-led health responses.
Improve Prevention and Diagnostics
Expand access to HPV vaccination, cervical cancer prevention, STI testing, diagnostics, and early treatment.
Support Adolescents and Communities
Strengthen person-centred sexual health services and community-led outreach for adolescents and underserved populations.
Translate Evidence into Policy
Collect member evidence and country examples to develop practical policy papers, recommendations, and advocacy messages.
Build Global Partnerships
Engage civil society, technical partners, and global health platforms to advance coordinated HIV and STI action.
Priorities
Expand HIV and STI Prevention
Improve Testing, Treatment and Care
Integrate HIV and STI Services
Secure Sustainable Financing
Advance Equity and Human Rights
Strengthen Community Leadership
Facts
More than 1 Million Every Day
More than 1 million curable STIs are acquired every day worldwide.
The HIV Response Faces a Funding Gap
HIV funding reached US$17.6 billion in 2025, about 20% below the annual amount needed by 2030.
Cervical Cancer Is Largely Preventable
HPV vaccination, screening, and treatment can prevent most cervical cancer cases.
Young Women Face Disproportionate HIV Risk
Around 4,000 girls and young women aged 15–24 acquired HIV weekly in 2024.











